Morgan Stanley raised the firm’s price target on Plains GP Holdings (PAGP) to $23 from $19 and keeps an Equal Weight rating on the shares. Given tariff and other macro uncertainties, near-term performance could continue to favor defensive positioning in midstream and renewable infrastructure, the analyst tells investors in a note on the group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PAGP:
- Plains GP Holdings LP Exceeds Guidance, Sets Positive 2025 Outlook
- Plains GP Holdings Reports Strong 2024 Financial Results
- Options Volatility and Implied Earnings Moves Today, February 07, 2025
- PAGP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Plains GP Holdings price target raised to $24 from $23 at Raymond James